首页> International journal of pharmaceutics> A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.

A folate-targeted PEGylated cyclodextrin-based nanoformulation achieves co-delivery of docetaxel and siRNA for colorectal cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yifang,Zou

第一单位： School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China.

作者： Yifang,Zou ^[1] ; Fang,Xiao ^[2] ; Liu,Song ^[1] ; Bingxue,Sun ^[1] ; Dandan,Sun ^[1] ; Di,Chu ^[1] ; Limei,Wang ^[3] ; Shulan,Han ^[1] ; Zhuo,Yu ^[4] ; Caitriona M,O'Driscoll ^[5] ; Jianfeng,Guo ^[6]

作者单位： School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China. ^[1] Department of Pharmacy, the Second Hospital of Jilin University, Changchun 130041, China. ^[2] Department of Pharmacy, the General Hospital of FAW, Changchun 130011, China. ^[3] Department of Hepatopathy, Shuguang Hospital, Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. ^[4] Pharmacodelivery Group, School of Pharmacy, University College Cork, Cork T12 YN60, Ireland. Electronic address: caitriona.odriscoll@ucc.ie. ^[5] School of Pharmaceutical Sciences, Jilin University, Changchun 130021, China; Pharmacodelivery Group, School of Pharmacy, University College Cork, Cork T12 YN60, Ireland. Electronic address: jguo@jlu.edu.cn. ^[6]

关键词 Chemotherapy Colorectal cancer Combination therapy Gene therapy Nanoparticle